Site icon WSY TOP NEWS

Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China


The French drugmaker said that the investment of about 1 billion euros will enhance the production and manufacturing of insulin, focusing on serving local diabetic patients.

Exit mobile version